After surviving a heart attack, Sean Walkenhorst shares his appreciation of the first responders, nurses, doctors and staff at OHSU who took care of him during his hospitalization: “Everyone was a link in that chain. I am grateful to all of them and always will be."

An East Oregonian op-ed on the state’s budget references an OHSU study that found Oregon has a 50% service capacity deficiency in residential and behavioral health treatment.

Research presented by Saurabh Thosar, Ph.D., at the SLEEP 2023 conference tested whether circadian rhythms in systolic blood pressure during rested wakefulness and in response to a standardized mild exercise are disturbed in patients with obstructive sleep apnea compared to healthy individuals.

Continued coverage of research led by Jonah Sacha, Ph.D., on how stem cell transplantation can kill the virus that causes AIDS.

KOIN-TV covers the collaboration between Jeff Tyner, Ph.D., and the Portland Police Bureau to use a data-driven approach to increase the rate of recovering stolen vehicles.

The Gresham Outlook notes Robyn Philisytn received a Ford Opportunity Scholarship and will be attending Oregon Health & Science University.

KGW-TV profiles Annette Adkins, the second person in the country to undergo a new procedure to treat an intractable form of epilepsy. Kim Burchiel, M.D., says: “It’s a revolutionary technique in that we’re not removing something, but we’re actually implanting something that will grow and take root in the brain and will suppress the seizure activity.”

In a video interview with EndocrineToday, Maria Fleseriu, M.D., reviews the pituitary and adrenal research highlights presented at the annual meeting of the European Society of Endocrinology.

Researchers at the OHSU Knight Cancer Institute have secured more than $1 million to equip and expand a newly formed Knight Cancer Precision Biofabrication Hub to develop organs, bone for pioneering research into cancer, and more. Luiz Bertassoni, D.D.S., Ph.D., says: “The real focus is to recreate cancer tissues using these fabrication techniques. This will let us dissect the complexities of cancers and understand the contribution of each one of these cells and tumor building blocks.”

In a video interview with OncLive, Alexandra Sokolova, M.D., discusses key findings from a phase 3 clinical trial in patients with metastatic castration-resistant prostate cancer.